MTLS
Materialise NV
Price Chart
Latest Quote
$8.70
+0.05 (+0.58%)
Current Price
| Previous Close | $8.65 |
| Open | $8.60 |
| Day High | $8.70 |
| Day Low | $8.58 |
| Volume | 36,562 |
Stock Information
Note: Financial values converted from EUR to USD
| Shares Outstanding | 57.33M |
| Total Debt | $66.35M |
| Cash Equivalents | $149.07M |
| Revenue | $304.06M |
| Net Income | $14.72M |
| Sector | Technology |
| Industry | Software - Application |
| Market Cap | $498.81M |
| P/E Ratio | 31.07 |
| EPS (TTM) | $0.28 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $430.08M |
| Sales | $304.06M |
| Income | $14.72M |
| Book/sh | $4.94 |
| Cash/sh | $2.33 |
| Employees | 3K |
Financial Ratios
| Quick Ratio | 2.06 |
| Current Ratio | 2.41 |
| Debt/Eq | 23.23 |
| EPS Growth TTM | 1591.40% |
Returns & Margins
| ROA | 1.65% |
| ROE | 5.22% |
| Gross Margin | 57.23% |
| Operating Margin | 0.60% |
| Profit Margin | 4.84% |
Ownership
| Insider Ownership | 5.30% |
| Institutional Ownership | 14.25% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 33.67 |
| PEG | 1.26 |
| P/S | 1.83 |
| P/B | 1.76 |
Analyst Data
| Recommendation | none |
| Target Price | $8.75 |
Technical Indicators
| SMA20 | $8.39 |
| SMA50 | $7.80 |
| SMA200 | $6.37 |
| RSI | 58.33 |
| ATR | 0.2307 |
| Shares Float | 23.04M |
| Short Float | 2.00% |
| Short Ratio | 2.21 |
| Volatility | 1.33 |
| Rel Volume | 0.19 |
Performance History
| Week | +5.97% |
| Month | +1.40% |
| Quarter | +37.66% |
| 6 Months | +64.15% |
| YTD | +59.63% |
| Year | +44.04% |
| 3 Years | +71.60% |
| 5 Years | -60.62% |
| 10 Years | +19.18% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $8.70 | 36,562 |
| 2026-10-26 | $8.65 | 184,100 |
| 2026-10-23 | $8.63 | 137,100 |
| 2026-10-22 | $8.53 | 112,400 |
| 2026-10-21 | $8.47 | 138,000 |
| 2026-10-20 | $8.21 | 133,400 |
| 2026-10-19 | $8.11 | 170,900 |
| 2026-10-16 | $8.00 | 267,400 |
| 2026-10-15 | $8.12 | 422,400 |
| 2026-10-14 | $8.13 | 161,900 |
| 2026-10-13 | $8.13 | 70,200 |
| 2026-10-12 | $8.27 | 154,500 |
| 2026-10-09 | $8.30 | 346,000 |
| 2026-10-08 | $8.40 | 222,700 |
| 2026-10-07 | $8.50 | 118,400 |
| 2026-10-06 | $8.56 | 181,600 |
| 2026-10-05 | $8.55 | 164,500 |
| 2026-10-02 | $8.50 | 192,000 |
| 2026-10-01 | $8.50 | 344,900 |
| 2026-09-30 | $8.56 | 311,400 |
| 2026-09-29 | $8.75 | 389,300 |
| 2026-09-28 | $8.58 | 324,500 |
About Materialise NV
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
đ° Latest News
No news articles available at the moment. Check back later for updates on MTLS.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $114,018,885 | $115,274,223 | $110,232,641 | $101,240,732 |
| Cost Of Revenue | $128,886,272 | $130,298,949 | $124,742,644 | $116,042,936 |
| Total Revenue | $300,778,839 | $299,803,338 | $287,848,966 | $260,758,608 |
| Operating Revenue | $300,778,839 | $299,803,338 | $287,848,966 | $260,758,608 |
| Expenses | ||||
| Interest Expense | $1,924,028 | $1,459,879 | $1,967,858 | $2,300,517 |
| Total Expenses | $290,737,256 | $289,204,327 | $270,948,538 | $264,751,640 |
| Other Income Expense | $-2,730,951 | $2,366,824 | $-11,940,886 | $4,286,357 |
| Net Non Operating Interest Income Expense | $877,725 | $2,924,253 | $2,653,405 | $-1,617,217 |
| Total Other Finance Cost | $387,728 | $394,471 | $379,861 | $813,666 |
| Interest Expense Non Operating | $1,924,028 | $1,459,879 | $1,967,858 | $2,300,517 |
| Operating Expense | $161,850,984 | $158,905,378 | $146,205,895 | $148,708,704 |
| Other Operating Expenses | $-7,161,160 | $-7,190,380 | $-6,736,346 | $-7,174,646 |
| Selling And Marketing Expense | $12,148,798 | $12,331,985 | $11,729,603 | $13,263,655 |
| General And Administrative Expense | $96,096,879 | $95,727,133 | $89,690,945 | $91,273,323 |
| Other Non Operating Income Expenses | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $8,673,860 | $15,100,023 | $7,554,507 | $-2,385,930 |
| Net Interest Income | $877,725 | $2,924,253 | $2,653,405 | $-1,617,217 |
| Interest Income | $3,189,481 | $4,778,602 | $5,001,124 | $1,496,966 |
| Normalized Income | $10,722,073 | $12,855,901 | $19,357,858 | $-5,600,697 |
| Net Income From Continuing And Discontinued Operation | $8,673,860 | $15,100,023 | $7,554,507 | $-2,385,930 |
| Total Operating Income As Reported | $10,042,707 | $10,600,135 | $6,314,902 | $-3,227,692 |
| Net Income Common Stockholders | $8,673,860 | $15,100,023 | $7,554,507 | $-2,385,930 |
| Net Income | $8,673,860 | $15,100,023 | $7,554,507 | $-2,385,930 |
| Net Income Including Noncontrolling Interests | $8,671,612 | $15,066,308 | $7,524,163 | $-2,419,645 |
| Net Income Continuous Operations | $8,671,612 | $15,066,308 | $7,523,039 | $-2,419,645 |
| Pretax Income | $8,189,481 | $15,890,088 | $7,610,699 | $-1,323,893 |
| Special Income Charges | $0 | $0 | $-10,584,401 | $765,341 |
| Interest Income Non Operating | $3,189,481 | $4,778,602 | $5,001,124 | $1,496,966 |
| Operating Income | $10,041,583 | $10,599,011 | $16,900,428 | $-3,993,032 |
| Depreciation Amortization Depletion Income Statement | $9,525,736 | $9,431,333 | $9,730,277 | $10,560,801 |
| Depreciation And Amortization In Income Statement | $9,525,736 | $9,431,333 | $9,730,277 | $10,560,801 |
| Amortization Of Intangibles Income Statement | $9,525,736 | $9,431,333 | $9,730,277 | $10,560,801 |
| Gross Profit | $171,892,567 | $169,504,390 | $163,106,322 | $144,715,672 |
| Earnings From Equity Interest | - | - | - | $0 |
| Depreciation Income Statement | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $0.15 | $0.26 | $0.12 | $-0.04 |
| Basic EPS | $0.15 | $0.26 | $0.12 | $-0.04 |
| Other | ||||
| Tax Effect Of Unusual Items | $-682,738 | $122,702 | $-137,535 | $1,071,589 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $37,237,583 | $39,439,201 | $45,759,723 | $22,053,271 |
| Total Unusual Items | $-2,730,951 | $2,366,824 | $-11,940,886 | $4,286,357 |
| Total Unusual Items Excluding Goodwill | $-2,730,951 | $2,366,824 | $-11,940,886 | $4,286,357 |
| Reconciled Depreciation | $24,393,123 | $24,456,059 | $24,240,280 | $25,363,004 |
| EBITDA (Bullshit earnings) | $34,506,632 | $41,806,025 | $33,818,837 | $26,339,628 |
| EBIT | $10,113,509 | $17,349,967 | $9,578,557 | $976,624 |
| Diluted Average Shares | $66,387,955 | $66,425,042 | $66,402,565 | $66,378,964 |
| Basic Average Shares | $66,382,336 | $66,382,336 | $66,382,336 | $66,378,964 |
| Diluted NI Availto Com Stockholders | $8,673,860 | $15,100,023 | $7,554,507 | $-2,385,930 |
| Minority Interests | $2,248 | $33,715 | $30,344 | $32,592 |
| Tax Provision | $-482,131 | $823,781 | $87,660 | $1,095,752 |
| Impairment Of Capital Assets | $0 | $0 | $4,752,754 | $0 |
| Gain On Sale Of Security | $-2,730,951 | $2,366,824 | $-1,356,485 | $3,521,016 |
| Other Taxes | $-1,026,073 | $-1,400,315 | $-1,528,433 | $-996,853 |
| Provision For Doubtful Accounts | $469,769 | $106,766 | $503,484 | $-438,301 |
| Amortization | $9,525,736 | $9,431,333 | $9,730,277 | $10,560,801 |
| Research And Development | $51,797,035 | $49,898,856 | $42,816,365 | $42,220,725 |
| Selling General And Administration | $108,245,677 | $108,059,119 | $101,420,548 | $104,536,979 |
| Other Gand A | $9,849,405 | $8,040,009 | $8,104,069 | $7,012,812 |
| Salaries And Wages | $86,247,475 | $87,687,124 | $81,586,877 | $84,260,511 |
| Other Special Charges | - | - | $5,831,648 | $-765,341 |
| Write Off | - | - | - | $0 |
Fetched: 2026-10-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $209,893,243 | $196,913,921 | $182,091,488 | $165,121,382 |
| Total Assets | $472,742,208 | $445,421,461 | $445,751,872 | $462,196,017 |
| Total Non Current Assets | $221,440,782 | $231,313,787 | $213,717,698 | $218,978,431 |
| Other Non Current Assets | $686,671 | $1,065,408 | $610,250 | $657,451 |
| Non Current Prepaid Assets | $458,530 | $475,388 | $554,057 | $454,035 |
| Non Current Deferred Assets | $4,462,801 | $3,959,317 | $3,143,403 | $1,332,884 |
| Non Current Deferred Taxes Assets | $4,462,801 | $3,959,317 | $3,143,403 | $1,332,884 |
| Non Current Accounts Receivable | $5,579,906 | $5,079,793 | $5,020,229 | $4,657,227 |
| Investmentin Financial Assets | $0 | $4,488,649 | $4,207,687 | $4,271,747 |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | $0 | $4,488,649 | $4,207,687 | $3,926,725 |
| Goodwill And Other Intangible Assets | $77,319,625 | $82,449,992 | $83,862,669 | $92,190,383 |
| Other Intangible Assets | $28,814,341 | $33,686,223 | $35,360,757 | $42,567,994 |
| Current Assets | $251,300,302 | $214,108,797 | $232,035,298 | $243,216,463 |
| Other Current Assets | $6,174,421 | $7,625,309 | $418,071 | $1,060,913 |
| Hedging Assets Current | $48,325 | $0 | $156,215 | $293,324 |
| Assets Held For Sale Current | $4,848,281 | $0 | $0 | - |
| Current Deferred Assets | $6,759,946 | $5,957,519 | $5,041,583 | $4,672,960 |
| Inventory | $16,749,832 | $18,433,357 | $18,427,737 | $17,349,967 |
| Receivables | $66,216,006 | $67,118,456 | $64,619,018 | $61,526,188 |
| Other Receivables | $538,323 | $1,688,020 | $1,708,249 | $1,952,124 |
| Taxes Receivable | $3,935,716 | $5,809,171 | $3,686,222 | $2,209,485 |
| Accounts Receivable | $61,741,967 | $59,621,266 | $59,224,547 | $57,364,579 |
| Allowance For Doubtful Accounts Receivable | $-1,087,885 | $-749,607 | $-906,945 | $-449,539 |
| Gross Accounts Receivable | $62,829,852 | $60,370,872 | $60,131,493 | $57,814,118 |
| Cash Cash Equivalents And Short Term Investments | $150,503,490 | $114,974,156 | $143,372,674 | $158,313,110 |
| Cash And Cash Equivalents | $150,503,490 | $114,974,156 | $143,372,674 | $158,313,110 |
| Cash Equivalents | $4,575,186 | $5,597,887 | $8,953,698 | $129,061,592 |
| Cash Financial | $145,928,304 | $109,376,269 | $134,418,976 | $29,251,518 |
| Non Current Note Receivables | - | - | $0 | $0 |
| Debt | ||||
| Total Debt | $70,929,425 | $46,396,945 | $72,373,570 | $91,009,219 |
| Long Term Debt And Capital Lease Obligation | $59,326,817 | $31,790,291 | $43,734,549 | $68,577,211 |
| Long Term Debt | $55,884,471 | $26,045,180 | $37,741,067 | $62,792,765 |
| Current Debt And Capital Lease Obligation | $11,602,608 | $14,606,654 | $28,639,021 | $22,432,008 |
| Current Debt | $8,719,937 | $11,668,915 | $25,705,778 | $19,170,601 |
| Other Current Borrowings | $8,719,937 | $11,668,915 | $25,705,778 | $19,170,601 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $185,619,248 | $166,154,198 | $179,857,278 | $204,915,719 |
| Total Non Current Liabilities Net Minority Interest | $82,355,589 | $51,321,647 | $61,909,420 | $85,659,702 |
| Other Non Current Liabilities | $97,775 | $51,697 | $355,136 | $1,124 |
| Non Current Deferred Liabilities | $22,481,457 | $18,509,778 | $16,212,633 | $15,271,972 |
| Non Current Deferred Taxes Liabilities | $2,989,436 | $3,598,562 | $4,186,334 | $4,846,033 |
| Current Liabilities | $103,263,659 | $114,832,551 | $117,947,858 | $119,256,017 |
| Other Current Liabilities | $1,457,631 | $1,273,320 | $631,603 | $265,228 |
| Current Deferred Liabilities | $49,360,532 | $52,449,991 | $46,167,680 | $47,781,526 |
| Payables And Accrued Expenses | $40,842,888 | $46,502,587 | $42,509,554 | $48,777,255 |
| Payables | $24,604,406 | $29,483,031 | $27,098,225 | $29,772,984 |
| Total Tax Payable | $1,986,963 | $3,243,426 | $3,277,141 | $3,665,993 |
| Accounts Payable | $22,617,443 | $26,239,605 | $23,821,084 | $26,106,991 |
| Equity | ||||
| Common Stock Equity | $287,212,868 | $279,363,913 | $265,954,157 | $257,311,766 |
| Total Equity Gross Minority Interest | $287,122,960 | $279,267,262 | $265,894,594 | $257,280,298 |
| Stockholders Equity | $287,212,868 | $279,363,913 | $265,954,157 | $257,311,766 |
| Other Equity Interest | $-1,124 | $-1,124 | $-1,124 | $-1,124 |
| Gains Losses Not Affecting Retained Earnings | $23,188,358 | $-9,893,235 | $-8,255,788 | $-9,291,976 |
| Other Equity Adjustments | $23,188,358 | $-9,893,235 | $-8,255,788 | $-9,291,976 |
| Retained Earnings | $29,835,919 | $21,353,114 | $6,253,091 | $-1,301,416 |
| Long Term Equity Investment | - | - | - | $0 |
| Investments In Other Ventures Under Equity Method | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $66,382,545 | $66,382,545 | $66,382,545 | $66,382,545 |
| Share Issued | $66,382,545 | $66,382,545 | $66,382,545 | $66,382,545 |
| Tangible Book Value | $209,893,243 | $196,913,921 | $182,091,488 | $165,121,382 |
| Invested Capital | $351,817,276 | $317,078,008 | $329,401,002 | $339,275,131 |
| Working Capital | $148,036,643 | $99,276,246 | $114,087,440 | $123,960,445 |
| Capital Lease Obligations | $6,325,017 | $8,682,850 | $8,926,725 | $9,045,853 |
| Total Capitalization | $343,097,339 | $305,409,093 | $303,695,224 | $320,104,530 |
| Minority Interest | $-89,908 | $-96,651 | $-59,564 | $-31,468 |
| Additional Paid In Capital | $229,147,008 | $262,862,451 | $262,915,272 | $262,862,451 |
| Capital Stock | $5,042,706 | $5,042,706 | $5,042,706 | $5,042,706 |
| Common Stock | $5,042,706 | $5,042,706 | $5,042,706 | $5,042,706 |
| Non Current Deferred Revenue | $19,492,021 | $14,911,217 | $12,026,299 | $10,425,939 |
| Long Term Capital Lease Obligation | $3,442,347 | $5,745,111 | $5,993,482 | $5,784,446 |
| Long Term Provisions | $449,539 | $969,881 | $1,607,103 | $1,810,519 |
| Current Deferred Revenue | $48,913,241 | $51,694,765 | $45,842,888 | $46,888,067 |
| Current Capital Lease Obligation | $2,882,670 | $2,937,739 | $2,933,244 | $3,261,407 |
| Current Accrued Expenses | $16,238,481 | $17,019,556 | $15,411,329 | $19,004,271 |
| Investments And Advances | $0 | $4,488,649 | $4,207,687 | $4,271,747 |
| Goodwill | $48,505,284 | $48,763,769 | $48,501,912 | $49,622,389 |
| Net PPE | $132,933,249 | $133,795,240 | $116,319,402 | $115,414,704 |
| Accumulated Depreciation | $-125,583,282 | $-119,099,802 | $-108,395,149 | $-98,416,502 |
| Gross PPE | $258,516,531 | $252,895,043 | $224,714,551 | $213,831,206 |
| Construction In Progress | $4,439,200 | $29,813,442 | $14,096,427 | $17,930,996 |
| Other Properties | $5,578,782 | $5,397,842 | $5,070,803 | $7,198,247 |
| Machinery Furniture Equipment | $164,925,833 | $153,310,862 | $141,741,970 | $124,249,274 |
| Buildings And Improvements | $7,583,727 | $9,679,704 | $9,187,458 | $10,554,058 |
| Land And Improvements | $75,988,989 | $54,693,192 | $54,617,894 | $53,898,631 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $4,230,164 | $3,549,112 | $3,670,488 | $3,188,357 |
| Work In Process | $4,904,473 | $4,761,744 | $4,574,062 | $5,198,921 |
| Raw Materials | $7,615,195 | $10,122,500 | $10,183,188 | $8,962,689 |
| Dueto Related Parties Current | - | - | - | $0 |
| Available For Sale Securities | - | - | - | $345,021 |
| Investmentsin Joint Venturesat Cost | - | - | - | $0 |
| Duefrom Related Parties Non Current | - | - | - | - |
Fetched: 2026-10-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $10,179,816 | $5,708,024 | $9,436,952 | $-2,792,763 |
| Operating Activities | ||||
| Operating Cash Flow | $28,454,710 | $35,351,766 | $22,653,406 | $25,048,326 |
| Cash Flow From Continuing Operating Activities | $28,454,710 | $35,351,766 | $22,655,654 | $25,048,326 |
| Operating Gains Losses | $-248,370 | $-318,049 | $-572,039 | $346,145 |
| Investing Activities | ||||
| Capital Expenditure | $-18,274,894 | $-29,643,741 | $-13,216,454 | $-27,841,089 |
| Investing Cash Flow | $-10,904,698 | $-32,128,569 | $-12,403,911 | $-60,531,583 |
| Cash Flow From Continuing Investing Activities | $-10,904,698 | $-32,129,693 | $-12,403,911 | $-60,531,583 |
| Net Other Investing Changes | $6,933,019 | $1,124 | - | - |
| Financing Activities | ||||
| Financing Cash Flow | $19,131,266 | $-31,067,657 | $-25,138,234 | $-25,297,821 |
| Cash Flow From Continuing Financing Activities | $19,130,142 | $-31,068,781 | $-25,138,234 | $-25,297,821 |
| Net Other Financing Charges | $-2,409,530 | $92,156 | $-388,851 | $611,373 |
| Cash Dividends Paid | $0 | $0 | $0 | $0 |
| Issuance Of Capital Stock | - | $0 | $0 | $25,849 |
| Net Common Stock Issuance | - | $0 | $0 | $25,849 |
| Common Stock Issuance | - | $0 | $0 | $25,849 |
| Other | ||||
| Repayment Of Debt | $-15,869,859 | $-29,657,228 | $-22,782,649 | $-23,698,585 |
| Issuance Of Debt | $39,334,684 | $0 | $0 | - |
| End Cash Position | $150,503,490 | $114,974,156 | $143,372,674 | $158,313,110 |
| Beginning Cash Position | $114,974,156 | $143,372,674 | $158,313,110 | $220,305,695 |
| Effect Of Exchange Rate Changes | $-1,150,820 | $-552,933 | $-51,697 | $-1,211,508 |
| Changes In Cash | $36,680,154 | $-27,845,584 | $-14,888,740 | $-60,781,077 |
| Interest Paid Cff | $-1,924,028 | $-1,502,585 | $-1,966,734 | $-2,236,458 |
| Net Issuance Payments Of Debt | $23,464,824 | $-29,657,228 | $-22,782,649 | $-23,698,585 |
| Net Long Term Debt Issuance | $23,464,824 | $-29,657,228 | $-22,782,649 | $-23,698,585 |
| Long Term Debt Payments | $-15,869,859 | $-29,657,228 | $-22,782,649 | $-23,698,585 |
| Long Term Debt Issuance | $39,334,684 | $0 | $0 | - |
| Net Business Purchase And Sale | $0 | $-3,000,674 | $0 | $-32,920,882 |
| Purchase Of Business | $0 | $-3,000,674 | $0 | $-32,920,882 |
| Net Intangibles Purchase And Sale | $-2,437,627 | $-1,942,010 | $-2,837,716 | $-3,556,979 |
| Purchase Of Intangibles | $-2,437,627 | $-1,942,010 | $-2,837,716 | $-3,556,979 |
| Net PPE Purchase And Sale | $-15,400,091 | $-27,187,009 | $-9,566,195 | $-24,053,721 |
| Sale Of PPE | $437,177 | $514,722 | $812,542 | $230,389 |
| Purchase Of PPE | $-15,837,267 | $-27,701,732 | $-10,378,737 | $-24,284,110 |
| Taxes Refund Paid | $-1,209,261 | $-3,542,369 | $-3,075,972 | $-1,601,484 |
| Interest Received Cfo | $4,880,872 | $4,456,058 | $4,726,905 | $1,199,146 |
| Change In Working Capital | $-9,938,189 | $-1,593,617 | $-14,133,514 | $1,150,820 |
| Change In Payables And Accrued Expense | $-5,920,432 | $-10,115 | $-9,479,659 | $13,896,382 |
| Change In Payable | $-5,920,432 | $-10,115 | $-9,479,659 | $13,896,382 |
| Change In Inventory | $-1,015,959 | $-418,071 | $-905,822 | $-5,631,603 |
| Change In Receivables | $-3,001,798 | $-1,165,430 | $-3,748,033 | $-7,113,958 |
| Changes In Account Receivables | $-3,001,798 | $-1,165,430 | $-3,748,033 | $-7,113,958 |
| Other Non Cash Items | $1,501,461 | $-5,218,027 | $-1,291,301 | $-1,903,799 |
| Stock Based Compensation | $298,944 | $320,297 | $43,830 | $-157,339 |
| Provisionand Write Offof Assets | $605,754 | $870,982 | $357,384 | $1,975,725 |
| Asset Impairment Charge | $0 | $51,697 | $4,751,630 | $0 |
| Deferred Tax | $-501,236 | $802,428 | $82,041 | $1,095,752 |
| Deferred Income Tax | $-501,236 | $802,428 | $82,041 | $1,095,752 |
| Depreciation Amortization Depletion | $24,393,123 | $24,456,059 | $24,240,280 | $25,363,004 |
| Depreciation And Amortization | $24,393,123 | $24,456,059 | $24,240,280 | $25,363,004 |
| Amortization Cash Flow | $7,227,467 | $7,180,266 | $7,309,508 | $8,572,713 |
| Amortization Of Intangibles | $7,227,467 | $7,180,266 | $7,309,508 | $8,572,713 |
| Depreciation | $17,165,656 | $17,275,793 | $16,930,772 | $16,790,291 |
| Net Foreign Currency Exchange Gain Loss | $-152,843 | $32,592 | $-105,642 | $-43,830 |
| Gain Loss On Sale Of PPE | $-95,527 | $-350,641 | $-466,397 | $389,975 |
| Net Income From Continuing Operations | $8,671,612 | $15,066,308 | $7,524,163 | $-2,419,645 |
| Earnings Losses From Equity Investments | - | - | $0 | $0 |
| Proceeds From Stock Option Exercised | - | - | - | - |
| Interest Received Cfi | - | - | - | - |
| Net Investment Purchase And Sale | - | - | - | - |
| Purchase Of Investment | - | - | - | - |
| Change In Account Payable | - | - | - | - |
Fetched: 2026-10-20